For example, in leukemias and prostate cancer, promyelocytic leukemia (PML) plays a critical regulatory role by inhibiting HAUSP activity through death domain-associated protein (DAXX), which in turn favors PTEN nuclear localization41. This evidence concerns the gene PTEN and Familial prostate cancer.